JPMorgan analyst Chris Schott reiterated a Neutral on Regeneron Pharma (NASDAQ: REGN).The analyst comments "This morning, Regeneron announced its highly ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE